A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

NCT04804904 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetic Study

Interventions

DRUG: TQ-B3101

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.